Publicacions en col·laboració amb investigadors/es de Hospital Universitario Arnau de Vilanova (50)

2024

  1. Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study

    Atherosclerosis, Vol. 375, pp. 75-83

2022

  1. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild–Moderate Cardiovascular Risk

    Archivos de Bronconeumologia, Vol. 58, Núm. 6, pp. 490-497

2021

  1. Correction: Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness? (Hypertension Research, (2021), 44, 8, (978-987), 10.1038/s41440-021-00655-9)

    Hypertension Research

  2. Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?

    Hypertension Research, Vol. 44, Núm. 8, pp. 978-987

  3. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054

2018

  1. Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors

    Medicina Clinica, Vol. 151, Núm. 10, pp. 383-389

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

  2. High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease

    Mediators of Inflammation, Vol. 2017

  3. Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 11, pp. 1882-1891

2016

  1. A new gender-specific formula to estimate 24-hour urine protein from protein to creatinine ratio

    Nephron, Vol. 133, Núm. 4, pp. 232-238

  2. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia, Vol. 36, Núm. 4, pp. 389-396

  3. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 389-396

2015

  1. Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference

    Atherosclerosis, Vol. 241, Núm. 1, pp. 264-270

  2. Impaired Vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: Implications for atherosclerosis development

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: Baseline data from the NEFRONA study

    BMC Nephrology, Vol. 15, Núm. 1

  2. The active form of vitamin D, calcitriol, induces a complex dual upregulation of endothelin and nitric oxide in cultured endothelial cells

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 307, Núm. 12, pp. E1085-E1096

2013

  1. A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients

    BMC Nephrology, Vol. 14, Núm. 1

  2. Papel de la ecografía carotídea en la reclasificación del riesgo cardiovascular de sujetos de riesgo bajo-intermedio

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 929-934